Effectiveness and safety of secukinumab in patients with moderate-severe psoriasis: A multicenter real-life study

Dermatologic Therapy
Antonio CarpentieriFrancesco Loconsole

Abstract

This study assessed the effectiveness and safety of secukinumab in patients with moderate-severe psoriasis vulgaris in a real-world setting. A total of 120 patients (35.8% women; mean age 49.8 years) were enrolled. Mean PASI significantly decreased from 12.0 ± 6.6 at baseline to 4.7 ± 3.2 and 2.3 ± 4.0 at 3 and 12 months, respectively (P < .001). Patients with two or more lines of prior biological therapies had poorer persistence to therapy at 12 months (71%) vs those who were bio-naïve (93%) or patients with only one prior failure with a biological agent (88%) (log-rank = 9.33; P = .009). Multivariate regression analysis showed that patients beyond the second line of treatment had an increased risk of discontinuing secukinumab (HR: 3.6; 95% CI 1.3-10.2), while those without comorbidities had a lower risk (HR: 0.31; 95% CI 0.1-0.8). Our study confirms the effectiveness and safety of secukinumab in a real-life setting for psoriatic disease.

References

Mar 26, 2003·Cytokine & Growth Factor Reviews·T A MoseleyA H Reddi
Oct 16, 2004·Immunity·Jay K Kolls, Anders Lindén
Mar 4, 2008·Journal of the American Academy of Dermatology·Alexa B KimballUNKNOWN National Psoriasis Foundation
Jan 24, 2009·Trends in Pharmacological Sciences·Stefan Ivanov, Anders Lindén
Jul 4, 2009·Nature Reviews. Immunology·Sarah L Gaffen
Jan 8, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·C PaulUNKNOWN CAIN457A2211 study group
Mar 25, 2014·Journal of the American Academy of Dermatology·Charles W LyndeSam Khalil
Jul 10, 2014·The New England Journal of Medicine·Richard G LangleyUNKNOWN FIXTURE Study Group
Aug 3, 2014·Cold Spring Harbor Perspectives in Medicine·Paola Di MeglioFrank O Nestle
Nov 22, 2014·Dermatologic Clinics·Caitriona Ryan, Brian Kirby
Feb 5, 2015·Drugs·Mark Sanford, Kate McKeage
Sep 9, 2016·Postȩpy dermatologii i alergologii·Agnieszka WasilewskaLidia Rudnicka
Oct 7, 2016·Journal of the American Academy of Dermatology·Alice GottliebMarina Milutinovic
Mar 1, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·P GisondiG Girolomoni
Nov 29, 2017·Journal of the American Academy of Dermatology·Jorge R GeorgakopoulosJensen Yeung
Feb 3, 2018·Dermatology and Therapy·Sebastian SpindeldreherFrank Kolbinger
Dec 1, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·K ReichG Di Comite
Feb 6, 2020·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Alice B GottliebLuminita Pricop

❮ Previous
Next ❯

Citations

Jul 27, 2021·Expert Opinion on Drug Safety·Bénédicte CaronLaurent Peyrin-Biroulet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annales de dermatologie et de vénéréologie
L Meunier, Groupe de recherche sur le psoriasis de la Société française de dermatologie
© 2021 Meta ULC. All rights reserved